381 related articles for article (PubMed ID: 26868758)
41. Human AK2 links intracellular bioenergetic redistribution to the fate of hematopoietic progenitors.
Oshima K; Saiki N; Tanaka M; Imamura H; Niwa A; Tanimura A; Nagahashi A; Hirayama A; Okita K; Hotta A; Kitayama S; Osawa M; Kaneko S; Watanabe A; Asaka I; Fujibuchi W; Imai K; Yabe H; Kamachi Y; Hara J; Kojima S; Tomita M; Soga T; Noma T; Nonoyama S; Nakahata T; Saito MK
Biochem Biophys Res Commun; 2018 Mar; 497(2):719-725. PubMed ID: 29462620
[TBL] [Abstract][Full Text] [Related]
42. The challenges and promises of blood engineered from human pluripotent stem cells.
Dravid GG; Crooks GM
Adv Drug Deliv Rev; 2011 Apr; 63(4-5):331-41. PubMed ID: 21232565
[TBL] [Abstract][Full Text] [Related]
43. Overlapping genes may control reprogramming of mouse somatic cells into induced pluripotent stem cells (iPSCs) and breast cancer stem cells.
Mosca E; Cocola C; Sabour D; Pelucchi P; Bertalot G; Palumbo O; Carella M; Götte M; Schöler HR; Reinbold R; Zucchi I; Milanesi L
In Silico Biol; 2010; 10(5-6):207-21. PubMed ID: 22430355
[TBL] [Abstract][Full Text] [Related]
44. Energy metabolism in neuronal/glial induction and in iPSC models of brain disorders.
Mlody B; Lorenz C; Inak G; Prigione A
Semin Cell Dev Biol; 2016 Apr; 52():102-9. PubMed ID: 26877213
[TBL] [Abstract][Full Text] [Related]
45. Quantitative proteomics of protein complexes and their implications for cell reprograming and pluripotency.
Sudhir PR; Kumari MP; Hsu WT; Massiot J; Chen CH; Kuo HC; Chen CH
J Proteome Res; 2013 Dec; 12(12):5878-90. PubMed ID: 24256468
[TBL] [Abstract][Full Text] [Related]
46. Genome-wide characterization of the routes to pluripotency.
Hussein SM; Puri MC; Tonge PD; Benevento M; Corso AJ; Clancy JL; Mosbergen R; Li M; Lee DS; Cloonan N; Wood DL; Munoz J; Middleton R; Korn O; Patel HR; White CA; Shin JY; Gauthier ME; Lê Cao KA; Kim JI; Mar JC; Shakiba N; Ritchie W; Rasko JE; Grimmond SM; Zandstra PW; Wells CA; Preiss T; Seo JS; Heck AJ; Rogers IM; Nagy A
Nature; 2014 Dec; 516(7530):198-206. PubMed ID: 25503233
[TBL] [Abstract][Full Text] [Related]
47. Induced pluripotent stem cells: progress and future perspectives in the stem cell world.
Rezanejad H; Matin MM
Cell Reprogram; 2012 Dec; 14(6):459-70. PubMed ID: 23035654
[TBL] [Abstract][Full Text] [Related]
48. Metabolic regulation of hematopoietic stem cells in the hypoxic niche.
Suda T; Takubo K; Semenza GL
Cell Stem Cell; 2011 Oct; 9(4):298-310. PubMed ID: 21982230
[TBL] [Abstract][Full Text] [Related]
49. Current progress and potential practical application for human pluripotent stem cells.
Philonenko ES; Shutova MV; Chestkov IV; Lagarkova MA; Kiselev SL
Int Rev Cell Mol Biol; 2011; 292():153-96. PubMed ID: 22078961
[TBL] [Abstract][Full Text] [Related]
50. Evolution of induced pluripotent stem cell technology.
Zhou H; Ding S
Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
[TBL] [Abstract][Full Text] [Related]
51. Interplay between Metabolites and the Epigenome in Regulating Embryonic and Adult Stem Cell Potency and Maintenance.
Harvey A; Caretti G; Moresi V; Renzini A; Adamo S
Stem Cell Reports; 2019 Oct; 13(4):573-589. PubMed ID: 31597110
[TBL] [Abstract][Full Text] [Related]
52. Direct Reprogramming of Human Amniotic Fluid Stem Cells by OCT4 and Application in Repairing of Cerebral Ischemia Damage.
Qin M; Chen R; Li H; Liang H; Xue Q; Li F; Chen Y; Zhang X
Int J Biol Sci; 2016; 12(5):558-68. PubMed ID: 27019637
[TBL] [Abstract][Full Text] [Related]
53. Different developmental potential of pluripotent stem cells generated by different reprogramming strategies.
Jiang J; Ding G; Lin J; Zhang M; Shi L; Lv W; Yang H; Xiao H; Pei G; Li Y; Wu J; Li J
J Mol Cell Biol; 2011 Jun; 3(3):197-9. PubMed ID: 21624975
[No Abstract] [Full Text] [Related]
54. NuRD blocks reprogramming of mouse somatic cells into pluripotent stem cells.
Luo M; Ling T; Xie W; Sun H; Zhou Y; Zhu Q; Shen M; Zong L; Lyu G; Zhao Y; Ye T; Gu J; Tao W; Lu Z; Grummt I
Stem Cells; 2013 Jul; 31(7):1278-86. PubMed ID: 23533168
[TBL] [Abstract][Full Text] [Related]
55. Regulation of embryonic stem cell self-renewal and differentiation by TGF-beta family signaling.
Fei T; Chen YG
Sci China Life Sci; 2010 Apr; 53(4):497-503. PubMed ID: 20596917
[TBL] [Abstract][Full Text] [Related]
56. Metabolic control of cancer cell stemness: Lessons from iPS cells.
Menendez JA
Cell Cycle; 2015; 14(24):3801-11. PubMed ID: 25738999
[TBL] [Abstract][Full Text] [Related]
57. Proteostatic and Metabolic Control of Stemness.
García-Prat L; Sousa-Victor P; Muñoz-Cánoves P
Cell Stem Cell; 2017 May; 20(5):593-608. PubMed ID: 28475885
[TBL] [Abstract][Full Text] [Related]
58. Pluripotent stem cell energy metabolism: an update.
Teslaa T; Teitell MA
EMBO J; 2015 Jan; 34(2):138-53. PubMed ID: 25476451
[TBL] [Abstract][Full Text] [Related]
59. Returning to the stem state: epigenetics of recapitulating pre-differentiation chromatin structure.
Shafa M; Krawetz R; Rancourt DE
Bioessays; 2010 Sep; 32(9):791-9. PubMed ID: 20652894
[TBL] [Abstract][Full Text] [Related]
60. An Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCs.
Menon S; Shailendra S; Renda A; Longaker M; Quarto N
Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26805822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
